P. Reddy

发表

Recent Advances and Future Directions

Pavan Reddy, P. Reddy, 2004 .

Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands

B. Ludewig, C. Ebens, Minhong Yan, 2017, The Journal of clinical investigation.

Blockade of individual Notch ligands and receptors controls graft-versus-host disease.

C. Ebens, Minhong Yan, C. Siebel, 2013, The Journal of clinical investigation.

Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease.

I. Maillard, P. Chockley, S. Winandy, 2011, Blood.

RNA-seq of Human T-Cells After Hematopoietic Stem Cell Transplantation Identifies Linc00402 as a Novel Regulator of T-Cell Alloimmunity

K. Oravecz-Wilson, P. Reddy, Yaping Sun, 2020, bioRxiv.

Pathophysiology of graft-versus-host disease.

J. Ferrara, P. Reddy, 2006, Seminars in hematology.

Graft-versus-host disease

E. Holler, J. Ferrara, J. Levine, 2009, The Lancet.

Prevention and Treatment of Acute GVHD in Children, Adolescents and Young Adults.

E. Gatza, P. Reddy, Sungwon Choi, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

SAG/RBX2 E3 Ubiquitin Ligase Differentially Regulates Inflammatory Responses of Myeloid Cell Subsets

Hua Li, Yi Sun, M. Tan, 2018, Front. Immunol..

Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation.

S. Choi, E. Gatza, F. Hoodin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Manipulating the Bioenergetics of Alloreactive T Cells Causes Their Selective Apoptosis and Arrests Graft-Versus-Host Disease

Thomas B. Sundberg, G. Glick, E. Gatza, 2011, Science Translational Medicine.

Mouse models of bone marrow transplantation.

G. Hill, R. Negrin, P. Reddy, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease.

A. Chinnaiyan, S. Mineishi, P. Lapinski, 2013, Blood.

The histone methyltransferase Ezh 2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease

A. Chinnaiyan, S. Mineishi, P. Lapinski, 2013 .

Immunobiology of acute graft-versus-host disease.

J. Ferrara, P. Reddy, 2003, Blood reviews.

New perspectives on the biology of acute GVHD

D. Hanauer, S. Paczesny, S Paczesny, 2010, Bone Marrow Transplantation.

Advances in understanding the pathogenesis of graft‐versus‐host disease

J. Magenau, P. Reddy, Lyndsey Runaas, 2016, British journal of haematology.

Mature T cell responses are controlled by microRNA-142.

T. Braun, R. McEachin, N. Mathewson, 2015, The Journal of clinical investigation.

Principles of hematopoietic cell transplantation

S. Choi, P. Reddy, 2015 .

α-1 antitrysin DAMPens GVHD.

P. Reddy, 2012, Blood.

Donor‐ but not host‐derived interleukin‐10 contributes to the regulation of experimental graft‐versus‐host disease

H. Tamaki, N. Mathewson, P. Reddy, 2012, Journal of leukocyte biology.

Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?

M. Imamura, S. Paczesny, P. Reddy, 2012, Current stem cell research & therapy.

Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease.

P. Reddy, T. Toubai, Yaping Sun, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Type I-IFNs interfere with GVH responses

P. Reddy, 2011, Blood.

A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease

W. Zou, S. Clouthier, R. Duran-Struuck, 2010, The Journal of Immunology.

Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation

Dafydd G. Thomas, G. Hill, P. Chockley, 2010, Clinical Cancer Research.

Cancer Therapy : Preclinical Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation

Dafydd G. Thomas, G. Hill, P. Chockley, 2010 .

Role of CXCR3-induced donor T-cell migration in acute GVHD.

S. Clouthier, U. Duffner, J. Ferrara, 2003, Experimental hematology.

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.

C. Dinarello, J. Ferrara, Y. Maeda, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Critical role of host γδ T cells in experimental acute graft-versus-host disease

J. Ferrara, Y. Maeda, D. Bishop, 2005 .

Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.

J. Ferrara, Y. Maeda, D. Bishop, 2005, Blood.

A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

R. Korngold, J. Ferrara, Y. Maeda, 2005, Nature Medicine.

Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease.

A. McKenzie, Y. Maeda, P. Reddy, 2008, Experimental hematology.

Cutting Edge: Negative Regulation of Dendritic Cells through Acetylation of the Nonhistone Protein STAT-31

C. Dinarello, E. Gatza, Y. E. Chin, 2009, The Journal of Immunology.

The Role of Dendritic Cells in Graft-Versus-Tumor Effect

N. Mathewson, P. Reddy, T. Toubai, 2014, Front. Immunol..

Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation

S. Choi, N. Mathewson, K. Oravecz-Wilson, 2015, Oncoimmunology.

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

J. Ferrara, P. Reddy, T. Teshima, 2002, Nature Medicine.

232: A critical role of CD100 in allogeneic immune responses

G. Luker, A. Kumanogoh, J. Ferrara, 2007 .

A novel role for the semaphorin Sema4D in the induction of allo-responses.

G. Luker, A. Kumanogoh, C. Rogers, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation.

K. Murphy, G. Luker, S. Choi, 2013, Blood.

Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function.

N. Mahmud, R. Hoffman, D. Mahmud, 2006, Blood.

Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation

H. Tamaki, D. Lombard, K. Oravecz-Wilson, 2018, The Journal of Immunology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

J. Ritz, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality

S. Paczesny, D. Couriel, A. Alousi, 2017, Bone Marrow Transplantation.

Current and emerging strategies for the prevention of graft-versus-host disease

S. Choi, P. Reddy, 2014, Nature Reviews Clinical Oncology.

Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect

S. Mineishi, P. Reddy, E. Peres, 2009, Bone Marrow Transplantation.

Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality.

S. Varambally, A. Chinnaiyan, C. Maher, 2011, Blood.

A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

T. Braun, P. Hari, M. Pasquini, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease.

M. Tanimoto, D. Hashimoto, Y. Maeda, 2007, Experimental hematology.

Donor Tregs suppress the good with the bad after allogeneic BMT.

S. Choi, P. Reddy, 2011, Leukemia research.

The ER cargo receptor SURF4 facilitates efficient erythropoietin secretion

Brian T. Emmer, A. B. Ozel, K. Desch, 2019, bioRxiv.

LNCing RNA to immunity.

P. Reddy, Daniel C Peltier, Alexis Roberts, 2022, Trends in immunology.

Targeting deacetylases to improve outcomes after allogeneic bone marrow transplantation.

P. Reddy, 2013, Transactions of the American Clinical and Climatological Association.

Outcomes after auto-SCT in African Americans with multiple myeloma

S. Mineishi, J. Levine, P. Reddy, 2009, Bone Marrow Transplantation.

Cognitive Function and Quality of Life in Vorinostat-Treated Patients Following Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplant

S. Choi, E. Gatza, F. Hoodin, 2019 .

Host-derived CD 8 1 dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation

K. Murphy, G. Luker, S. Choi, 2013 .

Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans.

C. Dinarello, S. Choi, E. Gatza, 2015, Blood.

Phase 1/2 trial of vorinostat plus tacrolimus and mycophenolate to prevent graft versus host disease following related donor reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

J. Dipersio, C. Dinarello, Thomas Braun, 2014 .

Differential susceptibility of C57BL/6NCr and B6.Cg-Ptprca mice to commensal bacteria after whole body irradiation in translational bone marrow transplant studies

J. Wilkinson, E. Gatza, S. Clouthier, 2008, Journal of Translational Medicine.

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation.

G. Hill, K. Gartlan, B. Blazar, 2015, Blood.

Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.

E. Gatza, C. Rogers, S. Clouthier, 2008, Blood.

Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner.

P. Reddy, T. Toubai, Yaping Sun, 2010, Blood.

Initiate Acute Graft-versus-Host Disease Host Dendritic Cells Alone Are Sufficient to

U. Duffner, J. Ferrara, Y. Maeda, 2004 .

Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease1

U. Duffner, J. Ferrara, Y. Maeda, 2004, The Journal of Immunology.

Flt 3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD 8 a 1 dendritic cells and reduces experimental acute graft-versus-host disease

J. Ferrara, P. Reddy, Chen Liu, 2002 .

Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease.

J. Ferrara, P. Reddy, Chen Liu, 2002, Blood.

graft-versus-host disease Impaired thymic negative selection causes autoimmune

P. Reddy, Chen Liu, T. Teshima, 2013 .

Tissue tolerance: a distinct concept to control acute GVHD severity.

P. Reddy, Shin-Rong Wu, 2017, Blood.

Mouse models of graft-versus-host disease

J. Ferrara, P. Reddy, 2009 .

Pathophysiology of Acute Graft-vs-Host Disease: Recent Advances

P. Reddy, T. Toubai, Yaping Sun, 2008 .

Pathophysiology of acute graft-versus-host disease: recent advances.

P. Reddy, T. Toubai, Yaping Sun, 2007, Translational research : the journal of laboratory and clinical medicine.

SUBSPECIALTY IN TRANSLATIONAL MEDICINE of acute graft-versus-host disease: recent advances

P. Reddy, T. Toubai, Yaping Sun, 2007 .

Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology

Michael D. Brooks, Ho-Joon Lee, A. Rehemtulla, 2021, Nature Immunology.

Aging is associated with increased regulatory T-cell function

R. Banerjee, A. Ghosh, S. Garg, 2014, Aging cell.

Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease.

S. Paczesny, J. Ferrara, P. Reddy, 2010, Immunotherapy.

K E ywords: autoimmunity n graft-versus-host disease n immunotherapy n mixed dimers n TC r cross-pairing n TCR gene therapy n TCR gene transfer n self-reactivity James Ferrara

S. Paczesny, P. Reddy, 2010 .

GVHD pathophysiology: is acute different from chronic?

P. Reddy, T. Toubai, Yaping Sun, 2008, Best practice & research. Clinical haematology.

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

J. Ferrara, P. Reddy, Chen Liu, 2002, Nature Medicine.

West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation

J. Ferrara, V. Ratanatharathorn, P. Reddy, 2004, Bone Marrow Transplantation.

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

T. Braun, M. Becker, G. Yanik, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rearrangement of T Cell genome architecture regulates GVHD

I. Rajapakse, Scott Ronquist, W. Meixner, 2021, bioRxiv.

Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation

M. Asaka, M. Imamura, J. Nishihira, 2009, International journal of laboratory hematology.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

T. Braun, R. Soiffer, C. Dinarello, 2018, Blood.

TRANSPLANTATION BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice

Shaomeng Wang, Depei Wu, N. Mathewson, 2015 .

Tolerance without toxicity? α1-antitrypsin as a novel alternative to immunosuppression

S. Goldstein, P. Reddy, 2012, Expert review of clinical immunology.

Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.

S. Clouthier, J. Ferrara, C. Min, 2004, Blood.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

T. Braun, S. Hanash, J. Ritz, 2013, The New England journal of medicine.

GVHD prevention: an ounce is better than a pound.

D. Weisdorf, G. Socié, C. Cutler, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

T. Braun, S. Choi, D. Couriel, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of interleukin-18 in acute graft-vs-host disease.

J. Ferrara, P. Reddy, 2003, The Journal of laboratory and clinical medicine.

Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.

R. Korngold, P. Reddy, T. Toubai, 2012, Blood.

Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival

T. Braun, S. Choi, J. Magenau, 2019, Bone Marrow Transplantation.

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

T. Braun, D. Hanauer, S. Choi, 2015, Bone Marrow Transplantation.

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation

T. Braun, M. Talpaz, S. Choi, 2021, Blood advances.

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.

N. Kröger, E. Holler, Y. Efebera, 2018, Blood.

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

N. Kröger, F. Locatelli, E. Holler, 2017, JCI insight.

Murine Models of Steroid Refractory Graft-versus-Host Disease

K. Oravecz-Wilson, P. Reddy, T. Toubai, 2018, Scientific Reports.

Emerging drugs for acute graft-versus-host disease

P. Reddy, O. Krijanovski, Y. Khaled, 2009, Expert opinion on emerging drugs.

Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML

S. Mineishi, S. Choi, G. Yanik, 2010 .

pneumonia syndrome after allogeneic bone marrow transplantation A critical role for CCR2/MCP-1 interactions in the development of idiopathic

C. Hogaboam, B. Moore, K. Olkiewicz, 2013 .

A critical role for CCR 2 / MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation

C. Hogaboam, W. Kuziel, B. Moore, 2004 .

GVHD: ferocity affects feracitas.

P. Reddy, 2017, Blood.

Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.

S. Clouthier, J. Ferrara, R. Levy, 2005, Blood.

Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.

S. Choi, Yang Liu, P. Zheng, 2014, Blood.

A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.

C. Hogaboam, W. Kuziel, B. Moore, 2004, Blood.

REVIEWARTICLE PATHOPHYSIOLOGY OF ACUTE GRAFT-VERSUS-HOST DISEASE

P. Reddy, 2003 .

Immunobiology of acute graft-versus-host disease Immunobiology of acute graft-versus-host disease

J. Ferrara, P. Reddy, 2003 .

Computational analysis of continuous body temperature provides early discrimination of graft-versus-host disease in mice.

M. Tewari, Zhenke Wu, S. Choi, 2019, Blood advances.

In response to "American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults".

P. Hari, B. Sandmaier, S. Davies, 2020, Blood advances.

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

H. Tamaki, K. Oravecz-Wilson, P. Reddy, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.

T. Braun, S. Mineishi, S. Choi, 2007, Blood.

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

M. Becker, J. Ferrara, V. Ratanatharathorn, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sugar polymers exacerbate lung GVHD.

N. Mathewson, Nathan D. Mathewson, P. Reddy, 2015, Blood.

Biology of graft-versus-host responses: recent insights.

K. MacDonald, P. Reddy, W. Shlomchik, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.

Scott E. Smith, T. Braun, D. Hanauer, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

T. Braun, S. Hanash, S. Mineishi, 2010 .

Siglec-G represses DAMP-mediated effects on T cells.

T. Braun, H. Tamaki, Yang Liu, 2017, JCI insight.

Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.

T. Braun, S. Choi, D. Couriel, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The difficulty in diagnosing cord colitis.

J. Magenau, P. Reddy, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic.

A. Casadevall, G. Semenza, G. Tomaselli, 2020, Journal of Clinical Investigation.

Biopsy‐proven adenoviral diarrhea responding to low‐dose cidofovir

P. Reddy, D. Kaul, N. Nicolasora, 2008, Transplant infectious disease : an official journal of the Transplantation Society.

Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

T. Braun, D. Hanauer, S. Choi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mouse models in bone marrow transplantation and adoptive cellular therapy.

M. Brenner, P. Reddy, C. Arber, 2013, Seminars in hematology.

Unusual presentations of lung cancer: Case 1. Diabetes insipidus as the initial manifestation of non-small-cell lung cancer.

G. Kalemkerian, P. Reddy, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

W. Wood, P. Chiusolo, R. Storb, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Etanercept plus topical corticosteroids as initial therapy for grade 1 acute graft-versus-host disease after allogeneic hematopoietic cell transplant

T. Braun, S. Choi, S. Paczesny, 2014 .

HDAC Inhibition and Graft Versus Host Disease

S. Choi, P. Reddy, 2011, Molecular medicine.

Cellular Therapy for Hematology Malignancies: Allogeneic Hematopoietic Stem Transplantation, Graft-Versus-Host Disease, and Graft Versus Leukemia Effects

J. Ferrara, P. Reddy, 2012 .

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.

J. Ferrara, P. Reddy, Chen Liu, 2003, Blood.

The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion

Brian T. Emmer, A. B. Ozel, K. Desch, 2020, Molecular and Cellular Biology.

PU.1-Dependent Transcriptional Regulation of miR-142 Contributes to Its Hematopoietic Cell–Specific Expression and Modulation of IL-6

Hiroya Tamaki, H. Tamaki, N. Mathewson, 2013, The Journal of Immunology.

IL-6 Specific Expression and Modulation of - Cell of miR-142 Contributes to Its Hematopoietic PU.1-Dependent Transcriptional Regulation

H. Tamaki, N. Mathewson, P. Reddy, 2013 .

Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stress

Nupur K. Das, J. Greenson, C. Lyssiotis, 2021, JCI insight.

IAPs protect host target tissues from graft-versus-host disease in mice.

Shaomeng Wang, C. Duckett, H. Tamaki, 2017, Blood advances.

Survival signal REG3&agr; prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease

M. V. D. van den Brink, J. Greenson, L. Hooper, 2018, The Journal of clinical investigation.

Intracellular Sensors and Cellular Metabolism in Allogeneic Hematopoietic Stem Cell Transplantation

P. Reddy, C. Byersdorfer, 2019, Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation.

Intracellular sensors of immunity and allogeneic hematopoietic stem cell transplantation

P. Reddy, Yaping Sun, 2013 .

Allogeneic T cell responses are regulated by a specific miRNA-mRNA network.

Hiroya Tamaki, Zhaohui S. Qin, Zhaohui S Qin, 2013, The Journal of clinical investigation.

Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis.

P. Reddy, M. Riwes, 2020, Seminars in hematology.

Mitochondrial Complex II In Intestinal Epithelial Cells Regulates T-cell Mediated Immunopathology

Michael D. Brooks, Ho-Joon Lee, A. Rehemtulla, 2020, bioRxiv.

Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.

T. Braun, S. Mineishi, S. Choi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease

Corinne Rossi, Subramaniam Pennathur, Hideaki Fujiwara, 2016, Nature Immunology.

Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

P. Reddy, R. Duran‐Struuck, 2008, Transplantation.

by oligonucleotide microarrays Early changes in gene expression profiles of hepatic GVHD uncovered

David E. Misek, R. Kuick, S. Hanash, 2013 .

Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

David E. Misek, R. Kuick, S. Hanash, 2003, Blood.

Emerging therapies in hematopoietic stem cell transplantation.

M. de Lima, P. Reddy, J. Koreth, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity

A. Chinnaiyan, A. Rao, D. Goldstein, 2021, Science Translational Medicine.

A Critical Analysis of the Role of SNARE Protein SEC22B in Antigen Cross-Presentation.

Y. Niknafs, D. Ginsburg, N. Mathewson, 2017, Cell reports.

Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells

Zhaohui S. Qin, Z. Qin, A. Chinnaiyan, 2016, Journal of Innate Immunity.

Microbial metabolites and graft versus host disease

P. Reddy, M. Riwes, Pavan Reddy, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis

J. Serody, J. Ferrara, Christopher M. Smith, 2017, The Journal of clinical investigation.

SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.

N. Mathewson, K. Oravecz-Wilson, P. Reddy, 2016, The American journal of pathology.

Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation.

U. Duffner, J. Ferrara, Y. Maeda, 2002, Blood.

Survival signal REG 3 a prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease

J. Greenson, L. Hooper, Ta-Chiang Liu, 2018 .

Pathophysiology of acute graft‐versus‐host disease

P. Reddy, 2003, Hematological oncology.

Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis

J. Ferrara, P. Reddy, Chen Liu, 2001, The Journal of experimental medicine.

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

T. Braun, J. Dipersio, C. Dinarello, 2014, The Lancet. Oncology.

SNARE protein SEC22B regulates early embryonic development

M. Hoenerhoff, D. Ginsburg, K. Oravecz-Wilson, 2019, Scientific Reports.

Clofarabine and Busulfan Conditioning Facilitates Engraftment and Provides Significant Anti-Tumor Activity in Non-Remission Hematologic Malignancies Running Title: CloBu4 conditioning for HSCT

T. Braun, K. Elenitoba-Johnson, S. Mineishi, 2016 .

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.

T. Braun, K. Elenitoba-Johnson, S. Mineishi, 2011, Blood.

GVHD: a continuing barrier to the safety of allogeneic transplantation.

C. Mackall, M. Arora, P. Reddy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Next generation treatment of acute graft-versus-host disease

J. Magenau, P. Reddy, 2014, Leukemia.

Microbial metabolite sensor GPR43 controls severity of experimental GVHD

M. V. D. van den Brink, Chen Liu, G. Núñez, 2018, Nature Communications.

Impaired thymic negative selection causes autoimmune graft-versus-host disease.

Chen Liu, Takanori Teshima, J. Ferrara, 2003, Blood.

Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

Thomas M Braun, Sophie Paczesny, Takanori Teshima, 2012, Blood.

Targeting Signal 3 Extracellularly and Intracellularly in Graft-Versus-Host Disease

P. Reddy, Stephanie Kim, 2020, Frontiers in Immunology.

Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin

Thomas M Braun, Hong Wang, Ying Wang, 2008, Science Translational Medicine.

A biomarker panel for acute graft-versus-host disease.

Thomas M Braun, Dawn Jones, Sophie Paczesny, 2009, Blood.

14 A phase I/II study of recombinant human keratinocyte growth factor (KGF) in patients with high risk hematologic malignancies undergoing mismatched related or unrelated donor transplant

T. Braun, M. Becker, G. Yanik, 2003 .

Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation.

T. Braun, S. Choi, G. Yanik, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease.

S. Grupp, Z. DeFilipp, K. Sigel, 2019, Blood advances.

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

Thomas M Braun, Sophie Paczesny, Elisabeth Huber, 2011, Blood.

Acute Graft-versus-Host Disease: Novel Biological Insights.

R. Zeiser, P. Reddy, T. Teshima, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights.

R. Zeiser, P. Reddy, T. Teshima, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

M. Caligiuri, C. Lengerke, B. Becher, 2018, Nature Medicine.

T Cell–Specific Notch Inhibition Blocks Graft-versus-Host Disease by Inducing a Hyporesponsive Program in Alloreactive CD4+ and CD8+ T Cells

P. King, T. Blackwell, I. Maillard, 2013, The Journal of Immunology.

This information is current as T Cells + and CD 8 + CD 4 Hyporesponsive Program in Alloreactive Graft-versus-Host Disease by Inducing a Specific Notch Inhibition Blocks − T Cell

P. King, T. Blackwell, I. Maillard, 2013 .

Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.

T. Braun, R. Hutchinson, U. Duffner, 2002, The Journal of clinical investigation.

Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

C. Dinarello, E. Lewis, P. Reddy, 2011, Proceedings of the National Academy of Sciences.

Phase II Trial of Vorinostat plus Tacrolimus & Mycophenolate to prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant Blood and Marrow Transplantation Program University of Michigan Comprehensive Cancer Center

T. Braun, S. Choi, D. Couriel, 2012 .

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

T. Braun, V. Ratanatharathorn, P. Reddy, 2006, Bone Marrow Transplantation.

Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.

T. Braun, S. Mineishi, S. Choi, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission

T. Braun, S. Mineishi, S. Choi, 2015, Annals of Hematology.

BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Shaomeng Wang, Depei Wu, N. Mathewson, 2015, Blood.

Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation.

Florian Keusch, Sung Won Choi, Florian Keusch, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis.

T. Ley, J. Baty, D. Link, 2018, Cancer research.

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives

J. Magenau, N. Mathewson, P. Reddy, 2016, Front. Immunol..

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.

C. Dinarello, E. Gatza, S. Clouthier, 2008, The Journal of clinical investigation.

ATG5-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia

K. Oravecz-Wilson, P. Reddy, Yaping Sun, 2020, Cancer Research.

Interleukin-18: recent advances

P. Reddy, 2004, Current opinion in hematology.

Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition

H. Tamaki, S. Pennathur, A. Mathew, 2019, Nature Microbiology.

Murine Models of Steroid Refractory Graft-versus-Host Disease

K. Oravecz-Wilson, P. Reddy, T. Toubai, 2018, Scientific Reports.

Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation

P. Reddy, Daniel C Peltier, 2018, Front. Immunol..

after allogeneic bone marrow transplantation Interleukin-18 preserves a perforin-dependent graft-versus-leukemia effect

U. Duffner, J. Ferrara, Y. Maeda, 2013 .

MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells.

D. Link, M. Colonna, Ming O. Li, 2019, Immunity.

Proteasome: target for acute and chronic GVHD?

J. Magenau, P. Reddy, 2014, Blood.

Neddylation plays an important role in the regulation of murine and human dendritic cell function.

H. Tamaki, N. Mathewson, K. Oravecz-Wilson, 2013, Blood.

Cohesin Releasing Factor WAPL Regulates Genome Structure and Function of Mature T Cells

I. Rajapakse, Scott Ronquist, W. Meixner, 2021 .

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.

T. Braun, C. Dinarello, S. Choi, 2017, Blood.

Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes

T. Braun, D. Hanauer, S. Choi, 2014, Bone Marrow Transplantation.

The Microbiome and Graft Versus Host Disease

N. Mathewson, P. Reddy, 2015, Current Stem Cell Reports.

Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis

S. Pennathur, L. Zeng, A. Mathew, 2020, The Journal of biological chemistry.

Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation.

R. Jenq, M. V. D. van den Brink, T. Schmidt, 2023, Immunity.

Inflammatory memory restrains intestinal stem cell regeneration

Michael D. Brooks, C. Creighton, Fengju Chen, 2023, Research square.

IMMUNOBIOLOGY Neddylation plays an important role in the regulation of murine and human dendritic cell function

Yi Sun, H. Tamaki, N. Mathewson, 2013 .

Blocking HDACs boosts regulatory T cells

W. Zou, P. Reddy, 2007, Nature Medicine.

Influence of donor microbiota on the severity of experimental graft-versus-host-disease.

G. Núñez, H. Tamaki, N. Mathewson, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

miR-142 controls metabolic reprogramming that regulates dendritic cell activation.

R. McEachin, T. Saunders, K. Oravecz-Wilson, 2019, The Journal of clinical investigation.

Microbial metabolite sensor GPR43 controls severity of experimental GVHD

M. V. D. van den Brink, Chen Liu, G. Núñez, 2018, Nature Communications.

Editorial: HDAC inhibition begets more MDSCs

P. Reddy, 2012, Journal of leukocyte biology.

Regulating Damage from Sterile Inflammation: A Tale of Two Tolerances.

P. Reddy, Shin-Rong Wu, 2017, Trends in immunology.

Analytic morphomics: a novel CT imaging approach to quantify adipose tissue and muscle composition in allogeneic hematopoietic cell transplantation

G. Yanik, J. Magenau, E. Gatza, 2016, Bone Marrow Transplantation.

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

T. Braun, P. Hari, M. Pasquini, 2017 .

The Microbiome and Graft Versus Host Disease

N. Mathewson, P. Reddy, 2015, Current Stem Cell Reports.

Unbiased Metabolic Profiling Uncovers a Crucial Role for the Microbial Metabolite Butyrate in Modulating GI Epithelial Cell Damage from Gvhd

S. Pennathur, A. Mathew, N. Mathewson, 2014 .

Erratum: Activin A programs the differentiation of human TFH cells

K. Honda, Pilar Martín, F. Sánchez‐Madrid, 2016, Nature Immunology.

Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML.

T. Braun, S. Mineishi, S. Choi, 2008 .

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.

N. Kröger, F. Locatelli, E. Holler, 2018, JCI insight.

Histone Deacetylase Inhibitors: Novel Immunomodulators

P. Reddy, Yaping Sun, 2007 .

Microbes and Their Metabolites Correlate with Hematopoietic Stem Cell Transplantation Outcomes?

P. Reddy, M. Riwes, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

35: Histone deacetylase inhibitors induce indoleamine 2, 3-dioxygenase and modulate dendritic cell functions

C. Dinarello, J. Ferrara, Y. Maeda, 2007 .

Impact of Automated Genotyping and Increased Breeding Oversight on Overall Mouse Breeding Colony Productivity

K. Oravecz-Wilson, P. Reddy, Z. T. Freeman, 2022, Frontiers in physiology.

Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

David E. Misek, R. Kuick, S. Hanash, 2003, Blood.

Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition

H. Tamaki, S. Pennathur, A. Mathew, 2019, Nature Microbiology.

Chemoprevention: general perspective.

I. Shureiqi, D. Brenner, P. Reddy, 2000, Critical reviews in oncology/hematology.

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

M. Becker, J. Ferrara, V. Ratanatharathorn, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extramedullary Relapse In Acute Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors And Outcomes

T. Braun, S. Mineishi, G. Yanik, 2010 .

A Pipeline for Faecal Host DNA Analysis by Absolute Quantification of LINE-1 and Mitochondrial Genomic Elements Using ddPCR

M. Tewari, E. Sandford, S. Choi, 2019, Scientific Reports.

IL-7: griffinesque role in GVHD

P. Reddy, 2007 .

Atypical E2F Dependent Dysregulation Of Cell Cycling By Microrna-142 Regulates T-Cell Responses and Experimental Graft-Versus-Host Disease

C. Ross, N. Mathewson, T. Saunders, 2013 .

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.

J. Ferrara, P. Reddy, Chen Liu, 2003, Blood.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

T. Braun, S. Hanash, J. Ritz, 2013, The New England journal of medicine.

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

T. Braun, S. Choi, D. Couriel, 2017, Biology of Blood and Marrow Transplantation.

miR-142 controls metabolic reprogramming that regulates dendritic cell activation.

R. McEachin, T. Saunders, K. Oravecz-Wilson, 2019, The Journal of clinical investigation.

Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.

R. Korngold, P. Reddy, T. Toubai, 2012, Blood.

A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease

W. Zou, R. Levy, Shawn G. Clouthier, 2010, The Journal of Immunology.

GVHD pathophysiology: is acute different from chronic?

P. Reddy, T. Toubai, Yaping Sun, 2008, Best practice & research. Clinical haematology.

The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

W. Wood, P. Chiusolo, R. Storb, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

T. Braun, R. Soiffer, C. Dinarello, 2018, Blood.

Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation.

Florian Keusch, J. Lepkowski, S. Choi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin

T. Braun, S. Hanash, D. Hanauer, 2010, Science Translational Medicine.

transplantation idiopathic pneumonia syndrome after allogeneic bone marrow A critical role for CCR 2 / MCP-1 interactions in the development

C. Hogaboam, K. Olkiewicz, U. Duffner, 2003 .

Manipulating the Bioenergetics of Alloreactive T Cells Causes Their Selective Apoptosis and Arrests Graft-Versus-Host Disease

Thomas B. Sundberg, G. Glick, E. Gatza, 2011, Science Translational Medicine.

Microbes and Their Metabolites Correlate with Hematopoietic Stem Cell Transplantation Outcomes?

P. Reddy, M. Riwes, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.

S. Choi, Yang Liu, P. Zheng, 2014, Blood.

ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity.

D. Ginsburg, K. Oravecz-Wilson, P. Reddy, 2021, The Journal of clinical investigation.

Impact of Dose Intensification of FluBu2 to FluBu4 on Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission

T. Braun, S. Mineishi, S. Choi, 2013 .

A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease.

T. Braun, S. Farag, S. Devine, 2023, Blood.

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation

K. Ichikawa, P. Reddy, T. Toubai, 2023, Blood advances.

Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

T. Braun, S. Choi, S. Paczesny, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.